
Organovo Holdings ONVO
Quarterly report 2025-Q4
added 02-11-2026
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
1.46 M |
Market Cap[1] |
$ 19.4 M |
EBITDA (LTM) |
$ -13.7 M |
P/E (LTM) |
- |
P/S (LTM) |
168.58 |
EPS (LTM) |
-5.43 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 202.18 | -0.43 % | $ 22.4 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 88.24 | -0.35 % | $ 4.13 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 3.78 | -11.89 % | $ 5.03 M | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 18.35 | -1.77 % | $ 565 M | Nasdaq Global Market | ||
|
Castle Biosciences
CSTL
|
$ 20.66 | -0.19 % | $ 599 M | Nasdaq Global Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Guardant Health
GH
|
$ 129.82 | -1.37 % | $ 16.3 B | Nasdaq Global Select Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.58 | -1.56 % | $ 6.99 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 24.08 | 4.83 % | $ 1.28 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 166.89 | 3.68 % | $ 25.9 B | Nasdaq Global Select Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 147.72 | 1.05 % | $ 11.6 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 154.47 | 2.03 % | $ 23.8 B | NYSE,SPB | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
National Research Corporation
NRC
|
$ 18.31 | -2.55 % | $ 410 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 216.97 | 2.31 % | $ 29.7 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 104.67 | 0.14 % | $ 7.06 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 188.47 | 0.51 % | $ 9.34 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Pacific Biosciences of California
PACB
|
$ 1.32 | 0.76 % | $ 396 M | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 467.5 | 0.03 % | $ 13.5 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
NeoGenomics
NEO
|
$ 11.09 | -0.54 % | $ 1.42 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.32 | -0.23 % | $ 400 M | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 9.79 | 2.09 % | $ 874 M | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 26.69 | 0.87 % | $ 25.3 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 7.24 | 0.84 % | $ 302 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.0 | -2.44 % | $ 4.59 M | Nasdaq Capital Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 80.79 | 6.07 % | $ 4.83 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 265.03 | -0.42 % | $ 22.1 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 473.72 | 1.03 % | $ 179 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.68 | 4.18 % | $ 244 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.3 | 2.2 % | $ 2.02 B | Nasdaq Global Select Market,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.